Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia.

Link to article at PubMed

Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia.

J Antimicrob Chemother. 2013 Jul 3;

Authors: Kim SH, Yoon YK, Kim MJ, Sohn JW

Abstract
OBJECTIVES: The time to positivity (TTP) of blood cultures is associated with the microbial load in the blood and prognosis in patients with bloodstream infections caused by various bacterial species. However, relevant information about the TTP for Candida species in candidaemia is limited. We investigated the clinical impact of the TTP on mortality in patients with candidaemia.
METHODS: All consecutive patients ≥18 years of age with candidaemia between January 2006 and July 2012 were included. The demographics, clinical and microbiological characteristics, antifungal treatment and outcomes of the patients were collected retrospectively.
RESULTS: A total of 152 patients were identified. The overall mortality rate at 6 weeks was 53%. The median TTP for Candida isolates was 27 h (IQR 19-37 h). A TTP of ≤24 h was significantly related to a higher mortality rate (P = 0.021). In a multivariate Cox regression analysis, the Charlson comorbidity index value [adjusted hazard ratio (HR) 1.15, 95% CI 1.02-1.29, P = 0.018], sequential organ failure assessment score (adjusted HR 1.23, 95% CI 1.13-1.34, P < 0.001), TTP ≤24 h (adjusted HR 2.74, 95% CI 1.51-4.97, P = 0.001), timing of appropriate antifungal therapy >72 h (adjusted HR 2.38, 95% CI 1.26-4.51, P = 0.008) and persistent candidaemia (adjusted HR 2.50, 95% CI 1.33-4.72, P = 0.005) were independently associated with the 6 week mortality rate.
CONCLUSIONS: A short TTP (≤24 h) for Candida species was independently associated with increased mortality in patients with candidaemia. Additional studies on the relevance of the TTP to clinical outcome in patients with candidaemia are needed.

PMID: 23825380 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.